Loading company…
multimmune GmbH is a Munich biotech developing cancer diagnostics and theranostic therapies targeting membrane Hsp70.
Founded in 1999 and based in Munich, Germany, multimmune GmbH develops cancer diagnostics and therapeutics, with a focus on theranostics. Its work centers on the membrane form of Hsp70, a protein found in many cancer cells. The company has completed 2 funding rounds, most recently on January 31, 2006, with undisclosed funding led by S-Refit and participation from Bayern Kapital. It is recorded at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in